• Home
  • Our Company
  • Our Partners
  • Our Solutions
  • More
    • Home
    • Our Company
    • Our Partners
    • Our Solutions
  • Home
  • Our Company
  • Our Partners
  • Our Solutions

Our Company

Our History

Founded in January 2018 as a University of Toronto/MaRS Innovation UTEST startup.  

Our Focus

We are developing new molecular matter as leads for the cure of neurodegenerative diseases including ALS, Alzheimer's and Parkinson's diseases

Our Location

We are located at the JLabs Toronto site in the MaRS West Tower


jlabs.jnjinnovation.com/locations/jlabs-toronto

Our Team

Peter Lewis PhD FCAHS CEO

Peter Lewis PhD FCAHS CEO

Peter Lewis PhD FCAHS CEO

Emeritus Professor of Biochemistry University of Toronto

50 years of research experience

25 years of science leadership

G. Angus McQuibban PhD CSO

Peter Lewis PhD FCAHS CEO

Peter Lewis PhD FCAHS CEO

Associate Professor of Biochemistry University of Toronto

25 years of research experience

John Reid PhD Executive In Residence

John Reid PhD Executive In Residence

John Reid PhD Executive In Residence


30 years of drug discovery and business

development experience

Naomi Visanji PhD Senior Scientist

John Reid PhD Executive In Residence

John Reid PhD Executive In Residence


Toronto Western Hospital

Edmond J. Safra program in Parkinson's disease 

Adjunct Lecturer Laboratory Medicine and Pathobiology

Copyright © 2022 Rosetta Therapeutics - All Rights Reserved.

  • Home
  • Our Company
  • Our Partners